Insmed (INSM) Return on Equity [ROE] (2009 - 2026)
Insmed (INSM) reported Return on Equity [ROE] of -119.72% for Q2 2026, up 33.64 percentage points from -153.36% a year earlier and up 44.26 percentage points from the prior quarter.
Powered by 
Analysis
Insmed (INSM) Return on Equity [ROE] (2009 - 2026) Analysis & Trends
For FY2025, Insmed posted Return on Equity [ROE] of -249.28%.
- Return on Equity [ROE] has a five-year change of -139.87 percentage points (FY2020 to FY2025).
- By year, Return on Equity [ROE] came in at -193.23% in FY2022 (-66.59 pp) and -126.64% in FY2021 (-17.23 pp).
- Five-year quarterly Return on Equity [ROE] spans a low of -6083.04% in Q3 2022 and a high of -81.83% in Q3 2021.
- Year over year, Return on Equity [ROE] has now increased in each of the last four quarters, with an average year-over-year change of +176.49 percentage points over the last four quarters.
- The high point for year-over-year Return on Equity [ROE] in five years was Q1 2026 (a gain of 363.03 percentage points); the low point was Q3 2022 (a drop of 6001.21 percentage points).
- Per Business Quant data, the three quarters before Q2 2026 came in at -163.98% (Q1 2026), -151.58% (Q4 2025) and -107.85% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 74.39% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 19.33% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | - |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 5.63% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 21.60% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 72.13% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -31.17% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 4.66% |
| 10 | Insmed | 26.21 Bn | 21.25 Bn | 446.21 Mn | -81.91% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -81.91% |
| Jun 30, 2026 | -120.41% |
| Mar 31, 2026 | -163.85% |
| Dec 31, 2025 | -151.14% |
| Sep 30, 2025 | -107.72% |
| Jun 30, 2025 | -152.68% |
| Mar 31, 2025 | -526.62% |
| Dec 31, 2024 | -238.12% |
| Sep 30, 2024 | -329.99% |
| Mar 31, 2023 | -2,519.12% |
| Dec 31, 2022 | -1,661.42% |
| Sep 30, 2022 | -6,103.84% |
| Jun 30, 2022 | -508.54% |
| Mar 31, 2022 | -165.16% |
| Dec 31, 2021 | -94.80% |
| Sep 30, 2021 | -81.84% |
| Jun 30, 2021 | -102.17% |
| Mar 31, 2021 | -133.70% |
| Dec 31, 2020 | -92.86% |
| Sep 30, 2020 | -64.21% |
API Access
Insmed Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=INSM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "INSM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=INSM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();